# Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies

> **NCT05148806** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 28411 (actual)

## Conditions studied

- Solid Organ Transplant Recipients
- Autoimmune Diseases
- Haematological Malignancies

## Interventions

- **DIAGNOSTIC_TEST:** self-administered lateral flow assays

## Key facts

- **NCT ID:** NCT05148806
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-07
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 28411 (ACTUAL)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05148806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05148806, "Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05148806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*